Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
US6569897B1 · kind B1 · utility
6Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 19, 2000 |
| Grant date | May 27, 2003 |
| Priority date | — |
| Expiry date | Jun 19, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D263/32
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Alkenyldiarylmethane (ADAM) compounds have been found effective as anti-HIV agents. Novel ADAM compounds, their pharmaceutical formulations and a method of using same to treat viral infections are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.